443 related articles for article (PubMed ID: 20868409)
1. Therapeutic hotline. Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
Lynn R; Krunic A
Dermatol Ther; 2010; 23(5):544-6. PubMed ID: 20868409
[TBL] [Abstract][Full Text] [Related]
2. High-grade prostate cancer and finasteride.
Lebdai S; Bigot P; Azzouzi AR
BJU Int; 2010 Feb; 105(4):456-9. PubMed ID: 19930174
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
Sato A; Takeda A
J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
[TBL] [Abstract][Full Text] [Related]
4. Finasteride (Propecia) and the promotion of high-grade prostate cancer.
Pitts WR
Arch Dermatol; 2004 Jul; 140(7):885-6. PubMed ID: 15262708
[No Abstract] [Full Text] [Related]
5. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
Arias-Santiago S; Camacho-Martínez FM
Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
[No Abstract] [Full Text] [Related]
6. The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.
Reed AB; Parekh DJ
Curr Opin Urol; 2009 May; 19(3):238-42. PubMed ID: 19318950
[TBL] [Abstract][Full Text] [Related]
7. [Finasteride adverse effects: An update].
Carreño-Orellana N; Moll-Manzur C; Carrasco-Zuber JE; Álvarez-Véliz S; Berroeta-Mauriziano D; Porras-Kusmanic N
Rev Med Chil; 2016 Dec; 144(12):1584-1590. PubMed ID: 28393993
[TBL] [Abstract][Full Text] [Related]
8. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.
Cohen YC; Liu KS; Heyden NL; Carides AD; Anderson KM; Daifotis AG; Gann PH
J Natl Cancer Inst; 2007 Sep; 99(18):1366-74. PubMed ID: 17848668
[TBL] [Abstract][Full Text] [Related]
9. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.
Rossi A; Cantisani C; Scarnò M; Trucchia A; Fortuna MC; Calvieri S
Dermatol Ther; 2011; 24(4):455-61. PubMed ID: 21910805
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics.
Keene S; Goren A
Dermatol Ther; 2011; 24(2):296-300. PubMed ID: 21410621
[TBL] [Abstract][Full Text] [Related]
11. The clinical applications of five-alpha reductase inhibitors.
Loughlin KR
Can J Urol; 2021 Apr; 28(2):10584-10588. PubMed ID: 33872554
[TBL] [Abstract][Full Text] [Related]
12. Finasteride-associated male infertility.
Chiba K; Yamaguchi K; Li F; Ando M; Fujisawa M
Fertil Steril; 2011 Apr; 95(5):1786.e9-11. PubMed ID: 21193189
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer risk among users of finasteride and alpha-blockers - a population based case-control study.
Murtola TJ; Tammela TL; Määttänen L; Hakama M; Auvinen A
Eur J Cancer; 2007 Mar; 43(4):775-81. PubMed ID: 17251005
[TBL] [Abstract][Full Text] [Related]
14. The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.
Theoret MR; Ning YM; Zhang JJ; Justice R; Keegan P; Pazdur R
N Engl J Med; 2011 Jul; 365(2):97-9. PubMed ID: 21675880
[No Abstract] [Full Text] [Related]
15. Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice.
Goetzl MA; Holzbeierlein JM
Nat Clin Pract Urol; 2006 Aug; 3(8):422-9. PubMed ID: 16902518
[TBL] [Abstract][Full Text] [Related]
16. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
Thompson IM; Chi C; Ankerst DP; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
J Natl Cancer Inst; 2006 Aug; 98(16):1128-33. PubMed ID: 16912265
[TBL] [Abstract][Full Text] [Related]
17. The finasteride prostate cancer prevention trial (PCPT)--what have we learned?
Mellon JK
Eur J Cancer; 2005 Sep; 41(13):2016-22. PubMed ID: 16061372
[TBL] [Abstract][Full Text] [Related]
18. Continuous finasteride therapy for benign prostate hypertrophy upgrades both neuroendorcine differentiation and aggressive prostate cancer.
Tarle M; Spajic B; Kraljic I; Kusic Z
Anticancer Res; 2009 May; 29(5):1797-801. PubMed ID: 19443407
[TBL] [Abstract][Full Text] [Related]
19. Finasteride: middle-age cure-all for alopecia and benign prostatic hyperplasia?
Federman DG
Mayo Clin Proc; 2006 Feb; 81(2):267; author reply 267-8. PubMed ID: 16471089
[No Abstract] [Full Text] [Related]
20. Guidelines on the use of finasteride in androgenetic alopecia.
Mysore V; Shashikumar BM
Indian J Dermatol Venereol Leprol; 2016; 82(2):128-34. PubMed ID: 26924401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
